These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29187463)

  • 1. Multi-Database Description of Primary Splenic Diffuse Large B-Cell Lymphoma.
    Byrd KP; Vontela NR; McCullar B; Martin MG
    Anticancer Res; 2017 Dec; 37(12):6839-6843. PubMed ID: 29187463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.
    Olszewski AJ; Ali S
    Ann Hematol; 2014 Mar; 93(3):449-58. PubMed ID: 24057925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival in advanced diffuse large B-cell lymphoma in pre- and post-rituximab Eras in the United States.
    Shah BK; Bista A; Shafii B
    Anticancer Res; 2014 Sep; 34(9):5117-20. PubMed ID: 25202101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis.
    Haque W; Dabaja B; Tann A; Khan M; Szeja S; Butler EB; Teh BS
    Radiother Oncol; 2016 Jul; 120(1):150-5. PubMed ID: 27373911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of primary splenic diffuse large B-cell lymphoma and role of splenectomy in improving survival.
    Bairey O; Shvidel L; Perry C; Dann EJ; Ruchlemer R; Tadmor T; Goldschmidt N
    Cancer; 2015 Sep; 121(17):2909-16. PubMed ID: 26096161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of Rituximab to Chemotherapy Reduced the Rate of Surgery for Gastric-DLBCL Without Increasing Early Mortality.
    Prouet P; Giri S; Wiedower E; Fintel A; Yaghmour G; Lamb EP; Deneve J; Fleming M; Dickson P; Chandler JC; Martin MG
    Anticancer Res; 2017 Feb; 37(2):813-817. PubMed ID: 28179335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Survival of Patients with Primary Gastric Diffuse Large B-Cell Lymphoma: An Analysis of 7051 Cases in the SEER Database.
    Liu PP; Xia Y; Bi XW; Wang Y; Sun P; Yang H; Li ZM; Jiang WQ
    Dis Markers; 2018; 2018():7473935. PubMed ID: 30410635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
    Castillo JJ; Winer ES; Olszewski AJ
    Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.
    Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJG; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
    Hematology; 2017 Aug; 22(7):405-411. PubMed ID: 28105889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features of splenic tumours of lymphoid tissue.
    Chen DB; Shen DH; Yang SM; Fang XZ
    Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar prognosis of transformed and de novo diffuse large B-cell lymphomas in patients treated with immunochemotherapy.
    Sorigue M; Garcia O; Baptista MJ; Sancho JM; Tapia G; Mate JL; Feliu E; Navarro JT; Ribera JM
    Med Clin (Barc); 2017 Mar; 148(6):243-249. PubMed ID: 28038857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of radiation therapy in primary mediastinal large B-cell lymphoma in rituximab era: A US population-based analysis.
    Giri S; Bhatt VR; Pathak R; Bociek RG; Vose JM; Armitage JO
    Am J Hematol; 2015 Nov; 90(11):1052-4. PubMed ID: 26270899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of radiation therapy in primary breast diffuse large B-cell lymphoma in the Rituximab era: a SEER database analysis.
    Liu PP; Wang KF; Jin JT; Bi XW; Sun P; Wang Y; Yang H; Li ZM; Jiang WQ; Xia Y
    Cancer Med; 2018 May; 7(5):1845-1851. PubMed ID: 29624913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
    Gundrum JD; Mathiason MA; Moore DB; Go RS
    J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of survival outcomes of different treatment modalities for patients with primary splenic diffuse large B cell lymphoma.
    Yonghao O; Yongyang W; Siqing Y; Lihua C; Shuju T
    Ann Hematol; 2023 Jul; 102(7):1857-1865. PubMed ID: 37188977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma.
    Williams JN; Rai A; Lipscomb J; Koff JL; Nastoupil LJ; Flowers CR
    Cancer; 2015 Jun; 121(11):1800-8. PubMed ID: 25675909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
    Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
    Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma.
    Griffiths RI; Gleeson ML; Mikhael J; Dreyling MH; Danese MD
    Cancer; 2012 Dec; 118(24):6079-88. PubMed ID: 22648454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of autoimmune disease affects not only risk but also survival in patients with B-cell non-Hodgkin lymphoma.
    Kleinstern G; Averbuch M; Abu Seir R; Perlman R; Ben Yehuda D; Paltiel O
    Hematol Oncol; 2018 Apr; 36(2):457-462. PubMed ID: 29469175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.